+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lithium distribution in mania plasma and red blood cell lithium clinical state and monoamine metabolites during lithium treatment



Lithium distribution in mania plasma and red blood cell lithium clinical state and monoamine metabolites during lithium treatment



Psychiatry Research 20(1): 1-12



We examined red blood cell (RBC) and plasma lithium concentrations and RBC/plasma lithium ratios in 14 manic patients during lithium treatment as part of the National Institute of Mental Health's Collaborative Program on the Psychobiology of Depression, Biological Studies. All of the lithium measures increased during treatment, especially RBC lithium. There were positive correlations between the RBC lithium concentration and the RBC/plasma lithium ratio and their maximal values in a single-dose pharmacokinetic experiment before treatment. After 5 and 16 days of treatment, patients with good subsequent outcome had higher RBC/plasma lithium ratios than did patients with poor outcome. Early in treatment, there was a negative correlation between lithium concentrations and severity of mania. During treatment, there was a negative correlation between RBC lithium and urinary MHPG excretion. There was a positive correlation between RBC or plasma lithium during the first few days of treatment and subsequent reduction in norepinephrine excretion during treatment. At 3 weeks, there were negative correlations between reductions in catecholamine measures and lithium concentrations. These data suggest that there are changes in the sensitivity of behavior and catecholamine function to lithium during treatment. RBC concentrations of lithium appear to be a potentially useful indictor of its behavioral and neurochemical effects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 005818881

Download citation: RISBibTeXText

PMID: 2882535

DOI: 10.1016/0165-1781(87)90118-1


Related references

Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (Lithium lipett C) and lithium carbonate tablets. Acta Psychiatrica Scandinavica 50(2): 174-182, 1974

Evaluation of the lithium red blood cell plasma ratio as a predictor of the prophylactic effect of lithium treatment in affective disorders. Pharmakopsychiatrie Neuro Psychopharmakologie: 81-84, 1976

Decay in plasma lithium and normalization in red blood cell choline following cessation of lithium treatment in two elderly individuals with Alzheimer-type dementia. Biological Psychiatry 19(6): 919-922, 1984

Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Archives of General Psychiatry 44(4): 345-354, 1987

Interindividual differences in the sodium ion dependent lithium ion counter transport system and in the lithium ion distribution ratio across the red cell membrane among lithium ion treated patients. Psychopharmacology 53(1): 19-26, 1977

Distribution of lithium in frog blood plasma and erythrocytes following a single administration of different doses of lithium carbonate. Farmakologiya i Toksikologiya 42(1): 26-29, 1979

Interdependency of lithium ratio plasma lithium level and clinical state in patients with affective disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 9(2): 167-172, 1985

Relationship between serum lithium level and clinical response in acute mania treated with lithium. British Journal of Psychiatry 120(557): 409-414, 1972

Lithium and electrolytes plasma red blood cell ratio and paradoxical lithium neuro toxicity. Progress in Neuro-Psychopharmacology & Biological Psychiatry 6(3): 235-241, 1982

The red blood cell lithium/plasma lithium ratio. Significance in recurrent affective illness. Medical Journal of Australia 1(13): 631-632, 1979

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. British Journal of Psychiatry 164(2): 149-152, 1994

The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144). Bipolar Disorders 15(1): 100-109, 2013

Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania. Journal of Clinical Psychopharmacology 14(5): 330-335, 1994

Locomotor activity and plasma, red blood cell and cerebral cortex lithium concentration in inbred mice given lithium carbonate. Pharmacology, Biochemistry, and Behavior 5(4): 379-382, 1976

Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms. Bipolar Disorders 10(8): 856-866, 2009